When a Good Scan Turns Into a Conversation About Surgery: Four Things That Decision Actually Rests On

When someone has been receiving chemotherapy for cancer that has already spread, and a scan comes back better than expected, the sentence "we could think about surgery" tends to land in two ways at once — as hope, and as doubt. What helps at that moment is not a fast conclusion, but separating out the different questions folded into that single sentence.

The first is what imaging can and cannot show. Shrinking or disappearing lesions on computed tomography (CT) or positron emission tomography (PET-CT) is a meaningful signal, but imaging has limits. Thin sheets of disease on the peritoneal surface can sit below the resolution of a scan, and tumours that produce a lot of mucin or have low cell density may not light up on PET. "Not visible" is not the same as "not there." This is why a diagnostic (staging) laparoscopy or peritoneal washing cytology is sometimes proposed before a surgical plan is finalised.

The second is the actual state of the abdominal cavity. How widely disease is distributed, and which organ surfaces it involves, changes what removal can realistically achieve. Direct visual findings plus tissue and cytology results are usually needed together, which is why two clinicians looking at the same scan may differ in how cautious they sound.

The third is what treatment has left behind in the body. Peripheral neuropathy after platinum-based drugs, hand-foot skin reactions, anaemia and blood count recovery, muscle mass and nutritional status, and immune-related adverse events such as thyroid or adrenal dysfunction after immune checkpoint inhibitors can all affect anaesthesia and healing. The gap between the last chemotherapy dose and the operation is also set with wound healing and infection risk in mind.

The fourth is the goal of the operation itself. Surgery aimed at removing as much disease as possible, surgery to relieve a blockage or bleeding, and surgery to confirm what is present in the abdomen are different undertakings. Plans can also change once the abdomen is opened, and an operation may end without resection. Reading how the consent form describes that scope, before signing, makes the post-operative explanation far less disorienting.

When the treating hospital and the operating hospital are different, tests are often repeated from the beginning. That is not because the earlier ones were wrong: findings change over time, the operating team needs to review images and endoscopy against its own standards, and pre-anaesthetic assessment and planning of resection margins require their own preparation.

Before the first surgical consultation, it helps to bring one page covering: the chemotherapy history (drug names, number of cycles, what changed and why, and the last dose date); side effects, separating those that persist from those that resolved; recent CT, PET-CT, endoscopy and biopsy dates with the institution, image discs, radiology reports, and whether tissue slides can be borrowed; all current medications, especially antithrombotics, diabetes drugs and steroids, plus supplements and herbal remedies; and three questions — what is the goal of this operation, what happens if resection turns out not to be feasible, and when and in what form systemic treatment resumes afterwards.

While waiting for a surgical date, emergencies are still judged separately. Sudden severe abdominal pain, repeated vomiting with a distended abdomen and no passage of gas or stool, yellowing of the eyes or skin, fever above 38°C with chills, black stools or vomiting blood, or rapid weight loss or breathlessness over a few days all warrant contacting the treating team or attending an emergency department rather than waiting for the appointment.

This article is general information and does not replace individual diagnosis or treatment. Because decisions depend heavily on stage, distribution of disease and overall condition, please discuss any specific choice with your own medical team.